Dasatinib and Apixaban (Eliquis 2.5 mg): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Dasatinib-related thrombocytopenia or platelet dysfunction can add to antithrombotic bleeding risk.
Clinical significance and safety
Eliquis 2.5 mg is an anticoagulant. Dasatinib can cause serious bleeding, and SPRYCEL warns that platelet inhibitors or anticoagulants may further increase hemorrhage risk. The treating team should review the indication, blood counts and bleeding symptoms; do not stop either treatment independently.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.